𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PATHOLOGIC PROGNOSTIC FACTORS IN DIFFUSE AGGRESSIVE NON-HODGKIN'S LYMPHOMA

✍ Scribed by Gascoyne, Randy D.

Book ID
122623347
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
938 KB
Volume
11
Category
Article
ISSN
0889-8588

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prognostic factors for patients with dif
Prognostic factors for patients with diffuse large cell or immunoblastic non-Hodgkin's lymphomas: Experience of the non-Hodgkin's lymphoma pathologic classification project
✍ Simon, Richard ;Durrleman, Sylvain ;Hoppe, Richard T. ;Bonadonna, Gianni ;Bloomf πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 678 KB

## Abstract Prognostic factors for long‐term survival of 312 patients with diffuse large cell or immunoblastic non‐Hodgkin's lymphoma are presented based on analysis of the multi‐institution clinicopathologic study sponsored by the National Cancer Institute. At the time of analysis, 75% of the pati

HOAP-Bleo as salvage therapy for diffuse
HOAP-Bleo as salvage therapy for diffuse aggressive non-Hodgkin's lymphoma
✍ R. Liang; D. Todd; T. K. Chan πŸ“‚ Article πŸ“… 1988 πŸ› Springer 🌐 English βš– 254 KB

A total of 30 patients with recurrent or unresponsive diffuse, aggressive non-Hodgkin's lymphoma, who had previously received doxorubicin, cyclophosphamide, vincristine, and prednisone with or without bleomycin were treated with a combination of doxorubicin, vincristine, ara C, prednisone, and bleom